OPEN END TURBO BEAR OPTIONSSCHEIN - ASTRAZENECA | Real-time BOERSE MUENCHEN 05:15:32 23/05/2024 pm IST | ||
| 0.75 EUR | -13.79% |
|
| Current month | -26.89% | ||
| 1 month | -55.84% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 23/24/23 | 0.75 | -13.79% |
| 22/24/22 | 0.87 | +11.54% |
| 21/24/21 | 0.78 | -32.17% |
| 20/24/20 | 1.15 | +3.60% |
| 17/24/17 | 1.11 | +4.72% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 05:15 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ASTRAZENECA PLC |
| Issuer | 
UniCredit
|
| WKN | HB8588 |
| ISIN | DE000HB85886 |
| Date issued | 01/07/2022 |
| Strike | 13,016 p |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.33 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.39 € |
|---|---|
| Lowest since issue | 0.72 € |
| Spread | 0.01 € |
| Spread % | 1.33% |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
157.3
USD
Average target price
169.7
USD
Spread / Average Target
+7.87%
- Stock Market
- Certificates
- Certificat
